2026 adjusted EPS guided above $3, over 40% growth
Guidance · revenue to $172B
Centene's Q4 2025 call focused on stabilizing Medicaid after a difficult year, with sequential HBR improvement into Q4. Management provided a 2026 EPS guide of greater than $3, implying more than 40% growth, driven by Marketplace margin recovery and continued Medicaid stability, while flagging policy-related costs like the No Surprises Act and a decline in Marketplace membership due to APTC expiration. Medicaid HBR improved to 93.0% in Q4, a 40bp sequential improvement, with management expecting a flat HBR in 2026.
Centene's Q4 2025 call focused on stabilizing Medicaid after a difficult year, with sequential HBR improvement into Q4. Management provided a 2026 EPS guide of greater than $3, implying more than 40% growth, driven by Marketplace margin recovery and continued Medicaid stability, while flagging policy-related costs like the No Surprises Act and a decline in Marketplace membership due to APTC expiration. Medicaid HBR improved to 93.0% in Q4, a 40bp sequential improvement, with management expecting a flat HBR in 2026.
Guidance · revenue to $172B
Medicaid HBR improved to 93.0% in Q4, a 40bp sequential improvement, with management expecting a flat HBR in 2026.
Reported gross margin was 15.18%, reinforcing the quarter's better-than-guided profitability.
Marketplace membership is expected to be around 3.5 million by end of Q1 2026, down from 5.5 million in December 2025, due to enhanced APTC expiration.
Management discussed integrating AI into operations, citing proof points in prior authorization, call centers, member engagement, and analytics for fraud detection, with plans to accelerate GenAI integration in 2026.
Management frames 2026 as a recovery year, with EPS expected to grow more than 40% driven by Medicaid stabilization, Marketplace margin recovery, and progress toward Medicare Advantage break-even. This is a cautiously long tone, acknowledging 2025 as a rough base but pointing to specific levers for improvement.
Management acknowledged 2025 challenges but expressed confidence in 2026 guidance and margin improvement, with a cautious but forward-looking stance.
“we'll be taking a more proactive, litigious posture as necessary. As an example, earlier this week, we filed a multimillion-dollar lawsuit against a New York provider alleging fraudulent manipulation of in-network and out-of-network claims.”
“we are pleased to have worked closely with Wakely, the independent actuarial firm, to support publication of a new report reflecting market-wide paid membership metallic tier distribution, and statewide average premium set to be released t…”
“We found children who had been in therapy for 5 to 10 years, where clinical evidence suggests the optimal duration is 2 to 3 years, as well as those enrolled in 40 hours per week of therapy instead of balanced school integrated care.”
“we completed a review of our provider contract portfolio in the quarter and adjusted certain receivables accordingly, which drove the slightly elevated HBR compared to expectations.”
| 지표 | 기간 | 범위 | 중간값 | 상태 |
|---|---|---|---|---|
| EPS | FY2026 | $3.00 | $3.00 | INITIATED |
| Op marginMARKETPLACE | FY2026 | 4% | 4% | INITIATED |
| Revenue | FY2026 | $170B–$174B | $172B | INITIATED |
| UnitsMEDICAID_MEMBERS | FY2026 | -6%–-5% | -5.5% | INITIATED |
| UnitsMARKETPLACE_MEMBERS | FY2026 | $3.5 | $3.5 | INITIATED |